- Home
- MVO vs TELA Comparison
MVO vs TELA Comparison
Compare MVO & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVO
- TELA
- Stock Information
- Founded
- MVO 2006
- TELA 2012
- Country
- MVO United States
- TELA United States
- Employees
- MVO N/A
- TELA N/A
- Industry
- MVO Oil & Gas Production
- TELA Medical/Dental Instruments
- Sector
- MVO Energy
- TELA Health Care
- Exchange
- MVO Nasdaq
- TELA Nasdaq
- Market Cap
- MVO 95.7M
- TELA 104.0M
- IPO Year
- MVO N/A
- TELA 2019
- Fundamental
- Price
- MVO $5.33
- TELA $2.72
- Analyst Decision
- MVO
- TELA Strong Buy
- Analyst Count
- MVO 0
- TELA 4
- Target Price
- MVO N/A
- TELA $9.25
- AVG Volume (30 Days)
- MVO 55.1K
- TELA 183.4K
- Earning Date
- MVO 01-01-0001
- TELA 03-20-2025
- Dividend Yield
- MVO 17.46%
- TELA N/A
- EPS Growth
- MVO N/A
- TELA N/A
- EPS
- MVO 1.46
- TELA N/A
- Revenue
- MVO N/A
- TELA $68,649,000.00
- Revenue This Year
- MVO N/A
- TELA $30.39
- Revenue Next Year
- MVO N/A
- TELA $25.51
- P/E Ratio
- MVO $7.29
- TELA N/A
- Revenue Growth
- MVO N/A
- TELA 29.34
- 52 Week Low
- MVO $8.85
- TELA $2.30
- 52 Week High
- MVO $13.95
- TELA $7.18
- Technical
- Relative Strength Index (RSI)
- MVO 30.14
- TELA 50.00
- Support Level
- MVO $5.36
- TELA $2.53
- Resistance Level
- MVO $5.62
- TELA $2.96
- Average True Range (ATR)
- MVO 0.23
- TELA 0.13
- MACD
- MVO 0.10
- TELA 0.02
- Stochastic Oscillator
- MVO 59.72
- TELA 44.19
About MVO MV Oil Trust Units of Beneficial Interests
MV Oil Trust is a statutory trust. Its underlying properties consist of MV Partners, LLC's (MV Partners) net interests in all of its oil and natural gas properties, which are located in the Mid-Continent region in the States of Kansas and Colorado. These oil and gas properties include producing oil and gas wells.
About TELA TELA Bio Inc.
TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. The company's second portfolio of products, the OviTex PRS Reinforced Tissue Matrix, addresses unmet needs in plastic and reconstructive surgery.